Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
 Arthur QIANG
Arthur QIANG

 Executive Director & Presiden


 Apricot Capital

Mr. Qiang Jing is currently the president of SinoMab BioScience Limited (3681. HK).


From 2010 to 2017, Mr. Qiang served as a Managing Director and the Head of research in medicine and healthcare of the Research Department of China International Capital Corporation Limited (“CICC”). During his tenure at CICC, Mr. Qiang won the first place in Asiamoney for healthcare of Asia region in 2017, and the first place for healthcare of Mainland China and Hong Kong for four consecutive years from 2014 to 2017. From 2015 to 2016, he was ranked the top three in the Greater China by Institutional Investor.


Mr. Qiang is a Chartered Financial Analyst (CFA) and a Certified Financial Risk Manager (FRM). Mr. Qiang had a further research of tumor biology at Harvard Medical School and majored in finance at Tsinghua University for his PhD; In 2010, he graduated from Fudan University with a Master's degree in finance and graduated from Shanghai Jiao Tong University in 2005 with a Bachelor's degree in pharmacy.